skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.6.0

Opposition

Number:91221504Filing Date:04/14/2015
Status:TerminatedStatus Date:10/29/2018
General Contact Number:571-272-8500
Interlocutory Attorney:ANDREW P BAXLEY
Paralegal Name:ELLEN YOWELL
Defendant
Name:Galderma S.A. and Nestlé Skin Health S.A.
Correspondence:G MATHEW LOMBARD
LOMBARD & GELIEBTER LLP
305 BROADWAY FL 7
NEW YORK, NY 10007
UNITED STATES
mlombard@LombardIP.com, ipdocket@LombardIP.com, mail@lgtrademark.com, ehuang@lgtrademark.com
Phone: 212-520-1172
 
Applications/registrations
 
Serial #:86229736Application FileAssignment
Application Status: ABANDONED - NO STATEMENT OF USE FILED
Mark: SKINNES
Plaintiff
Name:Joseph A Peri
Correspondence:ALLEN C OSTERGAR III
OSTERGAR LAW GROUP PC
27101 PUERTA REAL STE 450
MISSION VIEJO, CA 92691
UNITED STATES
aostergar@ostergar.com
Phone: 949-305-4590
 
Pleaded applications and registrations
 
Serial #:78143623Application FileAssignmentRegistration #:2796200
Application Status: REGISTERED AND RENEWED
Mark: SKINN
Prosecution History
#DateHistory TextDue Date
1710/29/2018TERMINATED
1610/29/2018BD DECISION: OPP DISMISSED W/O PREJ
1510/17/2018W/DRAW OF OPPOSITION
1409/17/2018RESPONSE DUE 30 DAYS (DUE DATE)10/17/2018
1307/21/2017SUSP PEND DISP OF CIVIL ACTION
1207/14/2017D RESP TO BD ORDER/INQUIRY
1106/14/2017RESPONSE DUE 30 DAYS (DUE DATE)07/14/2017
1006/14/2016SUSP PEND DISP OF CIVIL ACTION
906/07/2016STIP RESP TO BE ORDER/INQUIRY
806/07/2016D APPEARANCE / POWER OF ATTORNEY
705/23/2016RESPONSE DUE 30 DAYS (DUE DATE)06/22/2016
605/23/2015SUSP PEND DISP OF CIVIL ACTION
505/18/2015P MOT FOR EXT W/O CONSENT
404/27/2015D MOT TO SUSP PEND DISP CIV ACTION
304/14/2015PENDING, INSTITUTED
204/14/2015NOTICE AND TRIAL DATES SENT; ANSWER DUE:05/24/2015
104/14/2015FILED AND FEE
Results as of 02/16/2025 07:39 AM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY